|
Market Closed -
NSE India S.E.
10:11:04 14/08/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 2,318.40 INR | -0.07% |
|
+2.13% | +13.92% |
| 03/08 | Glenmark Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 01/08 | India's Glenmark Pharma posts higher quarterly profit on strong demand | RE |
| Market Cap | 654B 6.84B 5.91B 5.55B 5.05B 9.49B 9.65B 65.07B 25.44B 328B 25.69B 25.13B 1,089B | P/E 2026 |
44.2x | P/E 2027 * | 28.2x |
|---|---|---|---|---|---|
| Enterprise Value | 615B 6.43B 5.55B 5.22B 4.75B 8.92B 9.07B 61.16B 23.91B 308B 24.15B 23.62B 1,023B | EV / Sales 2026 |
3.51x | EV / Sales 2027 * | 3.81x |
| Free-Float |
51.04% | Yield 2026 |
0.12% | Yield 2027 * | 0.16% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | -0.07% | ||
| 1 week | +2.13% | ||
| Current month | +3.78% | ||
| 1 month | +0.74% | ||
| 3 months | +1.79% | ||
| 6 months | +16.06% | ||
| Current year | +13.92% |
| 1 week | 2,245 | 2,341.6 | |
| 1 month | 2,162 | 2,341.6 | |
| Current year | 1,842 | 2,474 | |
| 1 year | 1,792.6 | 2,474 | |
| 3 years | 722.1 | 2,474 | |
| 5 years | 348.5 | 2,474 | |
| 10 years | 161.65 | 2,474 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2000 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 27/05/2025 |
Indrajit Bose
PSD | President | - | 15/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 12/05/2011 | |
| Director/Board Member | 85 | 14/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.07% | +2.13% | +14.25% | +189.31% | 6.86B | ||
| -0.10% | -1.08% | +17.70% | +70.44% | 48.57B | ||
| -3.26% | -1.15% | +50.36% | +115.32% | 40.99B | ||
| -0.60% | -1.83% | -7.11% | +15.98% | 12.35B | ||
| -2.75% | +2.45% | +14.83% | +74.39% | 12.2B | ||
| -0.19% | -0.19% | +29.10% | +135.91% | 9.08B | ||
| +1.56% | +5.52% | +23.46% | +39.78% | 7.41B | ||
| +0.52% | +3.93% | +39.82% | -13.06% | 7.13B | ||
| -2.51% | +3.10% | -27.59% | +27.09% | 5.92B | ||
| +1.61% | +5.83% | +37.47% | +112.80% | 4.73B | ||
| Average | -0.58% | +1.77% | +19.23% | +76.80% | 15.52B | |
| Weighted average by Cap. | -1.12% | +1.13% | +24.80% | +81.70% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 153B 1.6B 1.38B 1.3B 1.18B 2.22B 2.26B 15.23B 5.95B 76.67B 6.01B 5.88B 255B | 168B 1.76B 1.52B 1.43B 1.3B 2.44B 2.48B 16.7B 6.53B 84.09B 6.59B 6.45B 279B |
| Net income | 20.53B 215M 185M 174M 158M 298M 303M 2.04B 798M 10.28B 806M 789M 34.17B | 23.11B 242M 209M 196M 178M 335M 341M 2.3B 899M 11.57B 907M 888M 38.46B |
| Net Debt | -39.29B -411M -355M -334M -303M -570M -580M -3.91B -1.53B -19.68B -1.54B -1.51B -65.39B | -14.47B -151M -131M -123M -112M -210M -214M -1.44B -563M -7.25B -568M -556M -24.09B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/08/26 | INR 2,318.40 | -0.07% | 629,081 |
| 13/08/26 | INR 2,320.00 | +1.31% | 413,167 |
| 12/08/26 | INR 2,290.00 | +0.62% | 464,575 |
| 11/08/26 | INR 2,276.00 | +1.10% | 284,670 |
| 10/08/26 | INR 2,251.30 | -1.22% | 257,787 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions

















